These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interferons in vitreoretinal diseases; a review on their clinical application, and mechanism of action. Afarid M; Azimi A; Meshksar A; Sanie-Jahromi F Int Ophthalmol; 2024 May; 44(1):223. PubMed ID: 38727788 [TBL] [Abstract][Full Text] [Related]
4. IFN-γ induces the upregulation of RFXAP via inhibition of miR-212-3p in pancreatic cancer cells: A novel mechanism for IFN-γ response. Ding G; Zhou L; Shen T; Cao L Oncol Lett; 2018 Mar; 15(3):3760-3765. PubMed ID: 29467893 [TBL] [Abstract][Full Text] [Related]
5. AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical models. Shih CS; Laurie N; Holzmacher J; Spence Y; Nathwani AC; Davidoff AM; Dyer MA Neuromolecular Med; 2009; 11(1):43-52. PubMed ID: 19306089 [TBL] [Abstract][Full Text] [Related]
6. Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and Daxx. Gaddy DF; Lyles DS J Virol; 2007 Mar; 81(6):2792-804. PubMed ID: 17192316 [TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. Del Monte P; Laurino C; Arvigo M; Palermo C; Minuto F; Barreca A J Endocrinol Invest; 2005 May; 28(5):432-9. PubMed ID: 16075927 [TBL] [Abstract][Full Text] [Related]
8. Novel non-viral method for transfection of primary leukemia cells and cell lines. Schakowski F; Buttgereit P; Mazur M; Märten A; Schöttker B; Gorschlüter M; Schmidt-Wolf IG Genet Vaccines Ther; 2004 Jan; 2(1):1. PubMed ID: 14715084 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis and cell growth inhibition as antitumor effector functions of interferons. Sangfelt ; Strander H Med Oncol; 2001; 18(1):3-14. PubMed ID: 11778967 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of treatment with interferon. Strander H Med Oncol Tumor Pharmacother; 1989; 6(1):87-91. PubMed ID: 2471026 [TBL] [Abstract][Full Text] [Related]
12. Interferon treatment of human malignancies--a short review. Einhorn S; Strander H Med Oncol Tumor Pharmacother; 1993; 10(1-2):25-9. PubMed ID: 7505041 [TBL] [Abstract][Full Text] [Related]
13. The role of interferons in the treatment of malignant neoplasms. Murren JR; Buzaid AC Yale J Biol Med; 1989; 62(3):271-90. PubMed ID: 2479178 [TBL] [Abstract][Full Text] [Related]
14. Clinical effects of interferon therapy with special emphasis on antitumor efficacy. Strander HA Acta Oncol; 1989; 28(3):355-62. PubMed ID: 2472823 [TBL] [Abstract][Full Text] [Related]
15. Interferon and malignant disease--how does it work and why doesn't it always? Grandér D; Einhorn S Acta Oncol; 1998; 37(4):331-8. PubMed ID: 9743454 [TBL] [Abstract][Full Text] [Related]